Skip to content

13F-HR filed by Logos Global Management LP

Logos Global Management LP filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 47 holding rows worth $771,303,000.

Accession
0001172661-22-001393
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 47 entries on the cover page, a total value of $771,303,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $771,303,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CYTOKINETICS INC23282W605COM NEW1,615,000$59,448,000thousands by filing date
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK3,011,352$50,892,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM900,000$45,729,000thousands by filing date
DESIGN THERAPEUTICS INC25056L103COM2,797,501$45,180,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM475,000$44,531,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM1,250,000$43,300,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM340,000$43,109,000thousands by filing date
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS950,000$41,686,000thousands by filing date
Ventyx Biosciences Inc92332V107Common Stock2,514,280$34,119,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock2,850,000$31,892,000thousands by filing date
IVERIC BIO INC46583P102COM1,800,000$30,294,000thousands by filing date
ARCUTIS BIOTHERAPEUTICS INC03969K108COM1,500,000$28,890,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM350,000$28,777,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM1,614,021$26,825,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM1,385,251$26,500,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock2,734,392$26,360,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK1,000,000$23,650,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR175,000$20,538,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM1,000,000$16,650,000thousands by filing date
OLEMA PHARMACEUTICALS INC68062P106COM3,743,875$15,949,000thousands by filing date
ATHIRA PHARMA INC04746L104COM717,285$9,683,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM1,400,000$9,506,000thousands by filing date
VERA THERAPEUTICS INC92337R101COMMON STOCK385,000$9,044,000thousands by filing date
SCHOLAR ROCK HLDG CORP80706P103COM675,000$8,701,000thousands by filing date
ANAPTYSBIO INC032724106COM300,000$7,422,000thousands by filing date
CENTURY THERAPEUTICS INC15673T100COM550,259$6,928,000thousands by filing date
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS454,545$4,077,000thousands by filing date
Instil Bio, Inc.45783C101Common Stock377,091$4,054,000thousands by filing date
TALARIS THERAPEUTICS INC87410C104COM306,236$3,013,000thousands by filing date
TYRA BIOSCIENCES INC90240B106COMMON STOCK252,726$2,704,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM96,912$2,212,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM200,000$2,094,000thousands by filing date
EDGEWISE THERAPEUTICS INC28036F105COM213,744$2,073,000thousands by filing date
SPRUCE BIOSCIENCES INC85209E109COM1,000,000$2,010,000thousands by filing date
NUVALENT INC COM670703107Stock134,650$1,870,000thousands by filing date
LIANBIO ADR53000N108COM412,837$1,532,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS300,000$1,497,000thousands by filing date
VIGIL NEUROSCIENCE INC92673K108COM205,595$1,445,000thousands by filing date
VISTAGEN THERAPEUTICS INC92840H202COM1,000,000$1,240,000thousands by filing date
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock286,652$1,158,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM150,000$1,124,000thousands by filing date
IKENA ONCOLOGY INC45175G108COM178,281$1,088,000thousands by filing date
BIOMEA FUSION INC09077A106CMN200,000$892,000thousands by filing date
SOMALOGIC INC83444K105COM100,000$802,000thousands by filing date
RAIN ONCOLOGY INC75082Q105COM134,194$680,000thousands by filing date
OMEGA THERAPEUTICS INC68217N105COMMON STOCK12,986$81,000thousands by filing date
NUVATION BIO INC67080N119WARR66,666$54,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-22-001393this filing2022-05-16acceptance time not in the bulk data set